Abstract
Exercise and pharmacologic therapies to prevent and treat cardiovascular disease have advanced largely through independent efforts. Understanding of first-line drug therapies, findings from preclinical animal studies, and the need for research initiatives related to complementary cardioprotective exercise-pharma interventions are reviewed from the premise that contemporary cardioprotective therapies must include adjunctive exercise and lifestyle interventions in addition to pharmacologic agents.
| Original language | English |
|---|---|
| Pages (from-to) | 5-17 |
| Number of pages | 13 |
| Journal | Exercise and Sport Sciences Reviews |
| Volume | 46 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 2018 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- cardioprotection
- heart disease
- ischemia-reperfusion injury
- pharmacotherapy
- preconditioning
Fingerprint
Dive into the research topics of 'Cardioprotective Exercise and Pharmacologic Interventions as Complementary Antidotes to Cardiovascular Disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver